Middle East & Africa Infectious Disease Molecular Diagnostics Market Size & Outlook
The infectious disease molecular diagnostics market in Middle East & Africa is expected to reach a projected revenue of US$ 735.9 million by 2030. A compound annual growth rate of 5.2% is expected of Middle East & Africa infectious disease molecular diagnostics market from 2025 to 2030.
Clinical Diagnostics
In Vitro Diagnostics
Infectious Disease Molecular Diagnostics Market Outlook
Abbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp
Other key industry trends
In terms of revenue, MEA region accounted for 3.4% of the global infectious disease molecular diagnostics market in 2024.
Globally, North America is projected to lead the regional market in terms of revenue in 2030.
Latin America is the fastest growing regional market and is projected to reach USD 1,034.5 million by 2030.
The Middle East & African (MEA) countries such as South Africa, Saudi Arabia, and the UAE are prospering economies. The market in this region is driven by high prevalence of infectious diseases, rise in consumer awareness, and improvements in healthcare infrastructure.
Thus, MEA is mostly an untapped market for infectious diseases molecular diagnostics. Economic development witnessed in emerging markets, such as South Africa, and high unmet healthcare needs are some of the primary growth drivers for this market.
There is high prevalence of communicable & infectious diseases in this region. However, ethical reasons, poor infrastructure, and affordability might hamper growth. Growing healthcare awareness, increasing initiatives undertaken by various NGOs, improved penetration of health insurance policies, and privatization are some of the factors anticipated to fuel regional market growth.
Middle East & Africa Infectious Disease Molecular Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Infectious Disease Molecular Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Reagents Product was the largest segment with a revenue share of 67.63% in 2024.
Horizon Databook has segmented the Middle East & Africa infectious disease molecular diagnostics market based on instruments product, reagents product, others product covering the revenue growth of each sub-segment from 2018 to 2030.
The Middle East & African (MEA) countries such as South Africa, Saudi Arabia, and the UAE are prospering economies. The market in this region is driven by high prevalence of infectious diseases, rise in consumer awareness, and improvements in healthcare infrastructure.
Thus, MEA is mostly an untapped market for infectious diseases molecular diagnostics. Economic development witnessed in emerging markets, such as South Africa, and high unmet healthcare needs are some of the primary growth drivers for this market.
There is high prevalence of communicable & infectious diseases in this region. However, ethical reasons, poor infrastructure, and affordability might hamper growth. Growing healthcare awareness, increasing initiatives undertaken by various NGOs, improved penetration of health insurance policies, and privatization are some of the factors anticipated to fuel regional market growth.
Middle East & Africa Infectious Disease Molecular Diagnostics Market Product Outlook (Revenue, USD Million , 2018-2030)
Instruments Product
Reagents Product
Services Product
Middle East & Africa Infectious Disease Molecular Diagnostics Market Test location Outlook (Revenue, USD Million , 2018-2030)
Hospitals
Clinics
Diagnostics Laboratories
Research Institutes
Middle East & Africa Infectious Disease Molecular Diagnostics Market Technology Outlook (Revenue, USD Million , 2018-2030)
Middle East & Africa Infectious Disease Molecular Diagnostics Market Application Outlook (Revenue, USD Million , 2018-2030)
Respiratory Diseases
Tuberculosis
Meningitis
Gastrointestinal Tract Infections
HPV
Sexually Transmitted Infection
Sepsis
Drug Resistance Disease
Others Application
Reasons to subscribe to Infectious Disease Molecular Diagnostics Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Infectious Disease Molecular Diagnostics Market Outlook databook
Our clientele includes a mix of Infectious Disease Molecular Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa Infectious Disease Molecular Diagnostics Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa Infectious Disease Molecular Diagnostics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Middle East Africa Infectious Disease Molecular Diagnostics Market, 2018-2030 (US$M)